UT-San Antonio, Health Science Center, Merck Pen Exclusive Deal to Develop Chlamydia Vaccine

The deal is the first revenue-generating license for any technology developed at UTSA, and is the first multi-institution license secured through a regional tech-management office created last year to negotiate deals for four UT institutions in south Texas.

Full-text access for registered users only. Existing users login here.
New to GenomeWeb? Register here quickly for free access.